I am a physician-scientist and a board-certified medical oncologist who works closely with our multidisciplinary team caring for patients with soft tissue and bone sarcomas, and melanomas. My research focus is on the pathogenesis and treatment of sarcomas. I am involved in a multidisciplinary effort with oncologists, pathologist, and surgeons to analyze tumor tissues and to develop clinical trials tailored to personalized therapy. My laboratory in the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center focuses on the study of critical genetic and epigenetic “drivers” and development of novel biomarkers and therapeutics in sarcomas, in particular GIST and MPNST, using cell, tissue and mouse models.
I am fluent in English and Mandarin.
- Clinical Expertise: Sarcomas of Soft Tissue and Bone; GIST
- Languages Spoken: English; Chinese
- Education: MD, Weill Cornell Medical College; PhD, The Rockefeller University
- Residencies: Brigham and Women's Hospital
- Fellowships: Memorial Sloan Kettering Cancer Center; The Rockefeller University
- Board Certifications: Internal Medicine; Medical Oncology
Chi P, Chen Y, Zhang L, Guo X, Wongvipat J, Shamu T, Fletcher JA, Dewell S, Maki RG, Zheng D, Antonescu CR, Allis CD, Sawyers CL.. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature 2010; 467 :849-53
Feng J, Chi P, Blanpied TA, Xu Y, Magarinos AM, Ferreira A, Takahashi RH, Kao HT, McEwen BS, Ryan TA, Augustine GJ, Greengard P.. Regulation of neurotransmitter release by synapsin III. Journal of Neuroscience 2002; 22 :4372-4380
Facinelli JV, Chi P, Riffle JS. Thermally stable electrostatic stabilizers for suspending thermoplastic particles in water.. Polymer 1995; 36(1) :759-764
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.